Atlas Trials

To Evaluate the Efficacy and Safety of JS002 in HoFH Patients

Clinical trial NCT04515927 · COMPLETED

Trial details

NCT number
NCT04515927
Sponsor
Shanghai Junshi Bioscience Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hyperlipemia
Start date
2020-08-17
Primary completion
2022-05-06
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.